Digital therapeutics company Biofourmis has appointed Jaydev Thakkar as its chief operating officer, and Milan Shah as its chief technology officer. Thakkar joins Boston-based Biofourmis after 14 years at Amgen (NASDAQ: AMGN), where he was most recently director of digital health and innovation. Shah joins from cybersecurity firm Uptycs, where he was co-founder and chief technology officer. Biofourmis is developing software-based therapies and other technologies for various parts of the healthcare system.